Senior insider sale
Chief Medical Officer at IMMUNOME INC. — senior position signals high conviction
$2.28M
110K shares
What this filing means
LECHLEIDER ROBERT plans to sell 110K shares of IMMUNOME INC. valued at approximately $2.28M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001959173-26-005049
Officer· Chief Medical Officer
Since Oct 2023
110K
Shares to sell
$2.28M
Approx. market value
55K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/2/2026
55KTotal acquired55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/2/2026 | Stock Option Exercise Cash | 55K | — |
| Total | 55K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
55K
Market value
$1.09M
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
55K
Market value
$1.19M
7/2/2026
Total
Units
110K
Value
$2.28M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 55K | $1.09M | — | Completed |
| Planned — Approximate Date | ||||
7/2/2026 | 55K | $1.19M | NASDAQ | Planned |
| Total | 110K | $2.28M | ||